News

News Archive

Chmp adopted positive opinion for elzonris (tagraxofusp), for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Chmp adopted positive opinion for elzonris (tagraxofusp), for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

FLORENCE, November 13th, 2020 – The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that the Committee for Medicinal Products...
Menarini against cancer: for a child, ‘home’ means family

Menarini against cancer: for a child, ‘home’ means family

The Menarini Group continues to stand firmly by the side of the Tommasino Bacciotti Foundation, which has spent over 20 years working with the Meyer Hospital in Florence on the Family...

Select a Year from the Archive

Our values

Our values

Everyday we put our values into action. 4 values, which have given life to Menarini and have shaped its history.

Read More

Our values

Follow our blog

Discover our stories from all over the world

Read More